Business Insider: MindMed just raised $6.2 million to try to make psychedelics without their characteristic hallucinogenic qualities

by Erin Brodwin Sep 30, 2019 Business Insider

A startup that wants to use psychedelics to treat addiction just raised $6.2 million from the host of Shark Tank and the architect behind the world’s biggest cannabis grower :

• A new company called MindMed just raised $6.2 million in a bid to make psychedelics without their characteristic hallucinogenic qualities.
• Investors in the round include ‘Shark Tank’ host Kevin O’Leary, as well as Bruce Linton, the architect behind the world’s biggest cannabis grower, Canopy Growth.
• MindMed says it’s currently focused on turning a drug inspired by the psychedelic ibogaine into a treatment for opioid addiction.